The Pulse of K-Entertainment

PrescriptionSongs
Label

PrescriptionSongs

Prescription Songs is the independent music-publishing company founded by Lukasz "Dr. Luke" Gottwald in 2009, built around songwriting, administration, and licensing rather than the usual fan-facing label model. The company's own website keeps the pitch simple: music publishing and licensing. That matters because Prescription Songs is less about idol-style branding and more about owning leverage where records actually get written.

Its importance shows up through the writers and producers in its orbit. The company has been tied to mainstream pop hitmaking for years, and its 2013 to 2017 joint publishing arrangement with Big Machine Records showed it was serious about building cross-market writing pipelines well before global pop collaboration became routine business language.

That publishing-first identity also gives the brand a direct K-pop angle. EJAE signed with Prescription Songs in 2025, extending the company's reach into one of the most globally networked songwriting ecosystems in music right now. In practice, Prescription Songs matters because it remains a focused independent rights company with real writer-development gravity.

Gallery

Fans Also Ask

What is Prescription Songs?
Prescription Songs is an independent music-publishing and licensing company founded in 2009 by Lukasz Dr. Luke Gottwald. Instead of operating like a classic artist label, it focuses on writers, producers, catalog administration, and dealmaking around songs that move through pop, sync, and global crossover markets.
Who founded Prescription Songs?
Prescription Songs was founded by Dr. Luke in 2009. He built it as a publishing company rather than a conventional front-facing label, which is why its business value is measured more through songwriter rosters, licensing reach, and catalog influence than through public artist branding alone.
Why does Prescription Songs matter in K-pop and global pop?
Prescription Songs matters because it has stayed competitive as an independent publisher in a market dominated by larger rights groups. Its 2025 signing of Korean American songwriter and artist EJAE also gave it a direct link into the current K-pop songwriting economy, where global credits and cross-border publishing deals increasingly shape the market.

Latest Articles

No articles about PrescriptionSongs yet

Check back soon for the latest coverage.